肝膽腸胃科MRI報告：S2/S3交接處為肝癌或良性腫瘤？需要進一步追蹤嗎？-肝膽腸胃科

MRI報告？

---

好幾年前家人做過肝癌手術恢復良好
持續每三個月持續追蹤
最近因CT 判斷肝有灰色陰影
所以醫生於下次做抽血和核子共振檢查

抽血檢驗（檢驗肝各項均正常值）
但核子共振報告指出
內容如下
MR of the Liver, Structural Report.
-Cor FIESTA +FS, Large FOV -Axi Dynamic LAVA 3D, 0, 30s, 1, 3, and 5 mins, 5-mm slice. Indication(s): HCC+CCC S/P OP. FU Comparison: CT on 20230608, 20220419 Findings: Tumor profiles: 1. Prior management: partial hepatectomy and S5/S6, S4/S5/S8 2. Local recurrence (viable): -A growing nodule with early enhancement and early washout at S2/S3 junction, about 2 cm in size, favor HCC. -About three poor enhanced nodules at S2, S6 and S7, about 0.5-1.3 cm in size, relatively stable or slightly larger than prior studies, suspect regenerative nodules or hypovascular HCCs, suggest closely f/u. 3. Interval change: The S2/S3 lesion is larger than prior study. 4. Portal vein: Patent. 5. Regional lymphadenopathy: nil. Cirrhosis of liver: nil. No ascites. Splenomegaly: no Portosystemic collaterals: nil. Biliary tree :unremarkable. Pancreas:unremarkable. Kidneys:unremarkable. Adrenals:unremarkable. Imp: A growing HCC at S2/S3 junction, 2cm, and several stable washout nodules at S2, S6, S7.

以上檢查
判斷s2/s3交接處 是肝癌的機率？
或者是良性腫瘤？
肝結節生成的可能嗎？
是否還要再進一步追蹤觀察？

---

小靖，30~39歲男性，詢問日期：2023/09/19